crispr cas9 cdna (Integrated DNA Technologies)
Structured Review

Crispr Cas9 Cdna, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 99/100, based on 4157 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr+cas9+cdna/pmc05603999-404-9-55?v=Integrated+DNA+Technologies
Average 99 stars, based on 4157 article reviews
Images
1) Product Images from "Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth"
Article Title: Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth
Journal: Proceedings of the National Academy of Sciences of the United States of America
doi: 10.1073/pnas.1701872114
Figure Legend Snippet: Deletion of the NR0B1 microsatellite reduces NR0B1 expression, impairs A673 cell growth, and inhibits colony formation. (A) Sequencing results validating knockout of the NR0B1 GGAA-microsatellite about 1.5 kb upstream of the NR0B1 TSS in A673 cells. The sgRNAs targeted to either side of this region are underlined. GGAA-microsatellite is highlighted red, and CRISPR/Cas9 deleted region is highlighted blue. Gel shows deletion of NR0B1 microsatellite region compared with control (nondeleted), with densitometry quantification on Right (P < 0.01). Data are represented as mean ± SEM (n = 2). (B) NR0B1 mRNA (P < 0.05) and protein expression levels in control and CRISPR/Cas9-mediated knockout of NR0B1 microsatellite in A673 Ewing sarcoma cells, with Western blot densitometry quantification on Right. Control CRISPR/Cas9 plasmids do not contain sgRNAs. Data are represented as mean ± SEM (n = 3). (C) Growth and colony formation assay quantification of CRISPR/Cas9 control vs. NR0B1 microsatellite knockout in A673 cells (P < 0.05). Data are represented as mean ± SEM (n = 3).
Techniques Used: Expressing, Sequencing, Knock-Out, CRISPR, Western Blot, Colony Assay
Figure Legend Snippet: Deletion of the NR0B1 microsatellite in other cell lines. (A) NR0B1 mRNA and protein expression levels in control and CRISPR/Cas9-mediated knockout of the NR0B1 microsatellite in TC-71 and EWS/502 Ewing sarcoma cells (P < 0.05). Data are represented as mean ± SEM (n = 3). (B) Growth curves and soft agar assay quantification for NR0B1 microsatellite deletion in two other Ewing sarcoma cell lines (TC-71 cells and EWS/502 cells). Growth curve data are represented as mean ± SEM (n = 4). Control vs. CRISPR for TC-71 and EWS/502 cells are each statistically significant (P < 0.05). Soft agar data are represented as mean ± SEM (n = 2). (C) Densitometry quantification of PCR-amplified NR0B1-microsatellite–containing region for A673 control (wild-type NR0B1-microsatellite) allele vs. CRISPR-Cas9 knockout (deleted NR0B1-microsatellite) allele at different time points for up to 3 wk postlentiviral infection. (D) NR0B1 mRNA and protein expression levels in control and CRISPR/Cas9-mediated knockout of the NR0B1 microsatellite in non-Ewing sarcoma HEK293 cells. Data are represented as mean ± SEM (n = 3). n.s., not statistically significant. (E) NR0B1 protein levels and colony formation assay quantification for A673 cells with NR0B1 cDNA rescue in CRISPR/Cas9 control vs. microsatellite knockout. n.s., not statistically significant. Data are represented as mean ± SEM (n = 2).
Techniques Used: Expressing, CRISPR, Knock-Out, Soft Agar Assay, Amplification, Infection, Colony Assay
